Bevatas 100 mg Injection Bevatas 100 mg Injection Bevatas 100 mg Injection

Bevatas 100 mg Injection

4163.0 INR/VIAL

Product Details:

  • Origin of Medicine INDIA
  • Physical Form Liquid
  • Recommended For DOCTOR
  • Quantity 50 Pieces
  • Click to view more
X

Bevatas 100 mg Injection Price And Quantity

  • 4163.0 INR/VIAL
  • 50 Piece

Bevatas 100 mg Injection Product Specifications

  • 50 Pieces
  • INDIA
  • DOCTOR
  • Liquid

Bevatas 100 mg Injection Trade Information

  • 1 Week

Product Description

Bevatas 100 mg solution for infusion is an innovative anti-cancer treatment designed to combat various malignancies, including colorectal cancer, non-small cell lung cancer, glioblastoma, kidney cancer, and ovarian cancer. This medication contains Bevacizumab, a powerful monoclonal antibody that effectively inhibits the action of vascular endothelial growth factor (VEGF), a protein that promotes the formation of blood vessels in tumors, thereby limiting their growth and spread. By disrupting the tumor's blood supply, Bevatas plays a crucial role in enhancing the effectiveness of other cancer therapies. It is important to note that patients receiving this infusion may experience side effects such as high blood pressure, bleeding, and gastrointestinal perforations, necessitating close monitoring by healthcare professionals. As with any medication, consulting your healthcare provider prior to use is essential to ensure it is the right choice for your specific condition and to discuss any potential interactions with other treatments. With its targeted action and collaborative approach in cancer care, Bevatas 100 mg is a vital option for those facing these challenging diagnoses. Embrace the power of advanced oncology solutions with Bevatas, and take a proactive step in your cancer treatment journey.
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Pharmaceutical Injection' category



Back to top